These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 33106114)

  • 1. Evaluation of models for predicting pediatric fraction unbound in plasma for human health risk assessment.
    Yun YE; Edginton AN
    J Toxicol Environ Health A; 2021 Jan; 84(2):67-83. PubMed ID: 33106114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Model qualification of the PK-Sim® pediatric module for pediatric exposure assessment of CYP450 metabolized compounds.
    Yun YE; Edginton AN
    J Toxicol Environ Health A; 2019; 82(14):789-814. PubMed ID: 31405354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Quantitative Structure Property Relationship Algorithms for Predicting Plasma Protein Binding in Humans.
    Yun YE; Tornero-Velez R; Purucker ST; Chang DT; Edginton AN
    Comput Toxicol; 2021 Feb; 17():100142. PubMed ID: 34017929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Physiologically Based Pharmacokinetic Models to Predict the Absorption of BCS Class I Drugs in Different Pediatric Age Groups.
    Liu XI; van den Anker JN; Burckart GJ; Dallmann A
    J Clin Pharmacol; 2021 Jun; 61 Suppl 1():S94-S107. PubMed ID: 34185902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigating the Role of Altered Systemic Albumin Concentration on the Disposition of Theophylline in Adult and Pediatric Patients with Asthma by Using the Physiologically Based Pharmacokinetic Approach.
    Rasool MF; Khalid R; Imran I; Majeed A; Saeed H; Alasmari F; Alanazi MM; Alqahtani F
    Drug Metab Dispos; 2020 Jul; 48(7):570-579. PubMed ID: 32393652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of Pediatric Pharmacokinetics for CYP3A4 Metabolized Drugs: Comparison of the Performance of Two Hepatic Ontogeny Within a Physiologically Based Pharmacokinetic Model.
    Codaccioni M; Southall RL; Dinh J; Johnson TN
    J Clin Pharmacol; 2024 Sep; 64(9):1083-1094. PubMed ID: 38696325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving Pediatric Protein Binding Estimates: An Evaluation of α1-Acid Glycoprotein Maturation in Healthy and Infected Subjects.
    Maharaj AR; Gonzalez D; Cohen-Wolkowiez M; Hornik CP; Edginton AN
    Clin Pharmacokinet; 2018 May; 57(5):577-589. PubMed ID: 28779462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Facing the Facts of Altered Plasma Protein Binding: Do Current Models Correctly Predict Changes in Fraction Unbound in Special Populations?
    Al-Qassabi J; Tan SPF; Phonboon P; Galetin A; Rostami-Hodjegan A; Scotcher D
    J Pharm Sci; 2024 Jun; 113(6):1664-1673. PubMed ID: 38417790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A physiologically based pharmacokinetic model to predict the pharmacokinetics of highly protein-bound drugs and the impact of errors in plasma protein binding.
    Ye M; Nagar S; Korzekwa K
    Biopharm Drug Dispos; 2016 Apr; 37(3):123-41. PubMed ID: 26531057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physiologically Based Pharmacokinetic Modeling of Oxycodone in Children to Support Pediatric Dosing Optimization.
    Zheng L; Xu M; Tang SW; Song HX; Jiang XH; Wang L
    Pharm Res; 2019 Oct; 36(12):171. PubMed ID: 31654287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of PBPK modeling across the pediatric age range using propofol as a case.
    Michelet R; Van Bocxlaer J; Allegaert K; Vermeulen A
    J Pharmacokinet Pharmacodyn; 2018 Dec; 45(6):765-785. PubMed ID: 30298439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive Pediatric Modeling and Simulation Using Ontogeny Information.
    Ince I; Solodenko J; Frechen S; Dallmann A; Niederalt C; Schlender J; Burghaus R; Lippert J; Willmann S
    J Clin Pharmacol; 2019 Sep; 59 Suppl 1():S95-S103. PubMed ID: 31502689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A workflow example of PBPK modeling to support pediatric research and development: case study with lorazepam.
    Maharaj AR; Barrett JS; Edginton AN
    AAPS J; 2013 Apr; 15(2):455-64. PubMed ID: 23344790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and evaluation of a generic physiologically based pharmacokinetic model for children.
    Edginton AN; Schmitt W; Willmann S
    Clin Pharmacokinet; 2006; 45(10):1013-34. PubMed ID: 16984214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug Distribution to Human Tissues: Prediction and Examination of the Basic Assumption in In Vivo Pharmacokinetics-Pharmacodynamics (PK/PD) Research.
    Poulin P
    J Pharm Sci; 2015 Jun; 104(6):2110-2118. PubMed ID: 25808270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Albumin and Uptake of Drugs in Cells: Additional Validation Exercises of a Recently Published Equation that Quantifies the Albumin-Facilitated Uptake Mechanism(s) in Physiologically Based Pharmacokinetic and Pharmacodynamic Modeling Research.
    Poulin P; Haddad S
    J Pharm Sci; 2015 Dec; 104(12):4448-4458. PubMed ID: 26457988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiologically based pharmacokinetic models in the prediction of oral drug exposure over the entire pediatric age range-sotalol as a model drug.
    Khalil F; Läer S
    AAPS J; 2014 Mar; 16(2):226-39. PubMed ID: 24399240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maximum likelihood estimation of renal transporter ontogeny profiles for pediatric PBPK modeling.
    Hunt JP; Dubinsky S; McKnite AM; Cheung KWK; van Groen BD; Giacomini KM; de Wildt SN; Edginton AN; Watt KM
    CPT Pharmacometrics Syst Pharmacol; 2024 Apr; 13(4):576-588. PubMed ID: 38156758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Comparative Study Between Allometric Scaling and Physiologically Based Pharmacokinetic Modeling for the Prediction of Drug Clearance From Neonates to Adolescents.
    Mahmood I; Tegenge MA
    J Clin Pharmacol; 2019 Feb; 59(2):189-197. PubMed ID: 30192373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-analysis of hepatic cytochrome P450 ontogeny to underwrite the prediction of pediatric pharmacokinetics using physiologically based pharmacokinetic modeling.
    Upreti VV; Wahlstrom JL
    J Clin Pharmacol; 2016 Mar; 56(3):266-83. PubMed ID: 26139104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.